Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis Published on: 19 March 2020 Downloads » Global Biopharmaceutical Industry Commitment to address Coronavirus Public Health Crisis Resources News Releases Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies Videos Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing – 19 March 2020 (Video) News Releases Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis Statements IFPMA Members’ support in countering the novel coronavirus (2019-nCoV) Videos The biopharmaceutical industry commitments to tackle the coronavirus pandemic (Video playlist) Videos The value of the Ethos in the context of COVID-19 Statements Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19″ Statements IFPMA remarks on intellectual property management and the global response to COVID-19 Statements IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools News Releases Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools Videos IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video) News Releases Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19 Related Blog Entries Supporting the global collaboration initiative to accelerate the development, production and equitable access to new COVID-19 tools 5 Questions to …. five leading biopharmaceutical company CEOs and top executives on the COVID-19 Pandemic Interview – BBC World Newshour – Biopharmaceutical industry commitments on COVID-19 Related Links Novel coronavirus (COVID-19) Novel coronavirus 2019-nCoV exposes a flaw in the Nagoya Protocol Access to COVID-19 Tools (act) Accelerator Related Topics COVID-19 Tags global health securityNovel Coronavirus (COVID-19)pandemicsVaccines